214450 — PharmaResearch Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩7tn
- KR₩7tn
- KR₩350bn
- 87
- 4
- 100
- 72
Annual cashflow statement for PharmaResearch Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 32,452 | 46,824 | 43,434 | 77,265 | 88,943 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5,681 | 7,017 | 25,099 | 15,815 | 47,336 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13,905 | 2,207 | -26,593 | -40,660 | -10,044 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 32,392 | 65,449 | 52,542 | 64,945 | 139,880 |
| Capital Expenditures | -35,383 | -23,788 | -17,758 | -13,197 | -38,725 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -826 | -69,966 | 5,850 | -31,471 | -186,813 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -36,209 | -93,755 | -11,908 | -44,668 | -225,538 |
| Financing Cash Flow Items | -21.9 | -90.3 | — | — | -15,636 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11,088 | 42,965 | -9,301 | -25,969 | 182,643 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6,977 | 14,959 | 31,257 | -5,687 | 98,103 |